313 related articles for article (PubMed ID: 17407167)
1. The impact of polyadenylation signals on plasmid nuclease-resistance and transgene expression.
Azzoni AR; Ribeiro SC; Monteiro GA; Prazeres DM
J Gene Med; 2007 May; 9(5):392-402. PubMed ID: 17407167
[TBL] [Abstract][Full Text] [Related]
2. The role of polyadenylation signal secondary structures on the resistance of plasmid vectors to nucleases.
Ribeiro SC; Monteiro GA; Prazeres DM
J Gene Med; 2004 May; 6(5):565-73. PubMed ID: 15133767
[TBL] [Abstract][Full Text] [Related]
3. Transgene expression of transfected supercoiled plasmid DNA concatemers in mammalian cells.
Maucksch C; Bohla A; Hoffmann F; Schleef M; Aneja MK; Elfinger M; Hartl D; Rudolph C
J Gene Med; 2009 May; 11(5):444-53. PubMed ID: 19263463
[TBL] [Abstract][Full Text] [Related]
4. High mobility group box 1 protein enhances polyethylenimine mediated gene delivery in vitro.
Shen Y; Peng H; Deng J; Wen Y; Luo X; Pan S; Wu C; Feng M
Int J Pharm; 2009 Jun; 375(1-2):140-7. PubMed ID: 19442462
[TBL] [Abstract][Full Text] [Related]
5. PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints.
Keravala A; Portlock JL; Nash JA; Vitrant DG; Robbins PD; Calos MP
J Gene Med; 2006 Aug; 8(8):1008-17. PubMed ID: 16779871
[TBL] [Abstract][Full Text] [Related]
6. Poly(glycoamidoamine)s for gene delivery: stability of polyplexes and efficacy with cardiomyoblast cells.
Liu Y; Reineke TM
Bioconjug Chem; 2006; 17(1):101-8. PubMed ID: 16417257
[TBL] [Abstract][Full Text] [Related]
7. Intranuclear fluorescence resonance energy transfer analysis of plasmid DNA decondensation from nonviral gene carriers.
Matsumoto Y; Itaka K; Yamasoba T; Kataoka K
J Gene Med; 2009 Jul; 11(7):615-23. PubMed ID: 19396931
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the nuclear delivery and intra-nuclear transcription of plasmid DNA condensed with micro (mu) and NLS-micro by cytoplasmic and nuclear microinjection: a comparative study with poly-L-lysine.
Akita H; Tanimoto M; Masuda T; Kogure K; Hama S; Ninomiya K; Futaki S; Harashima H
J Gene Med; 2006 Feb; 8(2):198-206. PubMed ID: 16285003
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localisation and pDNA condensation in non-viral gene delivery.
Collins E; Birchall JC; Williams JL; Gumbleton M
J Gene Med; 2007 Apr; 9(4):265-74. PubMed ID: 17397103
[TBL] [Abstract][Full Text] [Related]
10. The efficiency of nuclear plasmid DNA delivery is a critical determinant of transgene expression at the single cell level.
Glover DJ; Leyton DL; Moseley GW; Jans DA
J Gene Med; 2010 Jan; 12(1):77-85. PubMed ID: 19890943
[TBL] [Abstract][Full Text] [Related]
11. Controlling the kinetics of transgene expression by plasmid design.
Yew NS
Adv Drug Deliv Rev; 2005 Apr; 57(5):769-80. PubMed ID: 15757760
[TBL] [Abstract][Full Text] [Related]
12. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes.
Varga CM; Tedford NC; Thomas M; Klibanov AM; Griffith LG; Lauffenburger DA
Gene Ther; 2005 Jul; 12(13):1023-32. PubMed ID: 15815703
[TBL] [Abstract][Full Text] [Related]
13. Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.
Johansen J; Tornøe J; Møller A; Johansen TE
J Gene Med; 2003 Dec; 5(12):1080-9. PubMed ID: 14661183
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific gene expression, mediated by TFL-3, a cationic liposomal vector, is controlled by a post-transcription process of delivered plasmid DNA.
Li W; Ishida T; Tachibana R; Almofti MR; Wang X; Kiwada H
Int J Pharm; 2004 May; 276(1-2):67-74. PubMed ID: 15113615
[TBL] [Abstract][Full Text] [Related]
15. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles.
Cohen H; Levy RJ; Gao J; Fishbein I; Kousaev V; Sosnowski S; Slomkowski S; Golomb G
Gene Ther; 2000 Nov; 7(22):1896-905. PubMed ID: 11127577
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle dependent transcription, a determinant factor of heterogeneity in cationic lipid-mediated transgene expression.
Akita H; Ito R; Kamiya H; Kogure K; Harashima H
J Gene Med; 2007 Mar; 9(3):197-207. PubMed ID: 17351985
[TBL] [Abstract][Full Text] [Related]
17. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Zheng F; Shi XW; Yang GF; Gong LL; Yuan HY; Cui YJ; Wang Y; Du YM; Li Y
Life Sci; 2007 Jan; 80(4):388-96. PubMed ID: 17074366
[TBL] [Abstract][Full Text] [Related]
18. Vector-based in vivo RNA interference: dose- and time-dependent suppression of transgene expression.
Kobayashi N; Matsui Y; Kawase A; Hirata K; Miyagishi M; Taira K; Nishikawa M; Takakura Y
J Pharmacol Exp Ther; 2004 Feb; 308(2):688-93. PubMed ID: 14610223
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acid-matrix attachment recognition regions--as facilitators in plasmid transfer.
Chancham P; van Ijperen T; McDoom I; Hughes JA
J Drug Target; 2003 May; 11(4):205-13. PubMed ID: 14578107
[TBL] [Abstract][Full Text] [Related]
20. Sustained transgene expression via citric acid-based polyester elastomers.
Zhang XQ; Tang H; Hoshi R; De Laporte L; Qiu H; Xu X; Shea LD; Ameer GA
Biomaterials; 2009 May; 30(13):2632-41. PubMed ID: 19200593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
